Antonio Oliver

1995–2025 年に発表

214
論文数
24,662
被引用数
86
h 指数
196
i10 指数

被引用数

Antonio Oliver の年別被引用数1980 年: 被引用 1 件1990 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 14 件2001 年: 被引用 32 件2002 年: 被引用 67 件2003 年: 被引用 67 件2004 年: 被引用 79 件2005 年: 被引用 86 件2006 年: 被引用 79 件2007 年: 被引用 83 件2008 年: 被引用 95 件2009 年: 被引用 143 件2010 年: 被引用 164 件2011 年: 被引用 189 件2012 年: 被引用 160 件2013 年: 被引用 168 件2014 年: 被引用 179 件2015 年: 被引用 180 件2016 年: 被引用 152 件2017 年: 被引用 262 件2018 年: 被引用 245 件2019 年: 被引用 891 件2020 年: 被引用 1,107 件2021 年: 被引用 1,348 件2022 年: 被引用 985 件2023 年: 被引用 778 件2024 年: 被引用 1,209 件2025 年: 被引用 714 件2026 年: 被引用 15 件1981〜1989 年は被引用が無いため表示していません1991〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,596 件、この内訳の 16.7%スペイン: 引用元論文 949 件、この内訳の 10%イギリス: 引用元論文 648 件、この内訳の 6.8%中国: 引用元論文 616 件、この内訳の 6.5%イタリア: 引用元論文 457 件、この内訳の 4.8%フランス: 引用元論文 446 件、この内訳の 4.7%ドイツ: 引用元論文 394 件、この内訳の 4.1%オーストラリア: 引用元論文 326 件、この内訳の 3.4%カナダ: 引用元論文 303 件、この内訳の 3.2%インド: 引用元論文 264 件、この内訳の 2.8%スイス: 引用元論文 208 件、この内訳の 2.2%デンマーク: 引用元論文 200 件、この内訳の 2.1%
0%16.7%その他 32.7%

分野

  • Biochemistry, Genetics and Molecular Biology56.4%
  • Medicine25.2%
  • Environmental Science5%
  • Immunology and Microbiology4.1%
  • Mathematics2.1%
  • Engineering1.4%
  • その他5.8%

トピック

  • Antibiotic Resistance in Bacteria16.9%
  • Bacterial biofilms and quorum sensing8.3%
  • Antibiotics Pharmacokinetics and Efficacy5.2%
  • Antibiotic Use and Resistance4.2%
  • Bacterial Identification and Susceptibility Testing2.7%
  • SARS-CoV-2 and COVID-19 Research2.6%
  • その他60.1%

共著者

全論文

検索で開く
  1. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

    著者: , , , , , , , - Clinical Microbiology Reviews 2019 被引用: 956

  2. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update

    著者: , , - International Journal of Antimicrobial Agents 2020 被引用: 371

  3. ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

    著者: , , , , , , , , , , , , , - Clinical Microbiology and Infection 2015 被引用: 784

  4. The increasing threat of Pseudomonas aeruginosa high-risk clones

    著者: , , , - Drug Resistance Updates 2015 被引用: 651

  5. Antibiotic treatment of biofilm infections

    著者: , , , - Apmis 2017 被引用: 411

  6. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics

    著者: , , , , , , , , , , , , , , - EMBO Molecular Medicine 2020 被引用: 190

  7. Antimicrobial susceptibility testing in biofilm-growing bacteria

    著者: , , - Clinical Microbiology and Infection 2014 被引用: 529

  8. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carmen Aspíroz, Marisa Monforte, Pedro de la Iglesia-Martínez, Gemma Jiménez-Guerra, Elena Riera-Pérez, Carmen Collado, Carmen Gallegos, Xavier Mulet, Almudena Fernández-Muñoz, Miquel Àngel Sastre-Femenía, María Antonia Gomis-Font, Laura Zamorano, Antonio Oliver, María Siller‐Ruiz, Jorge Calvo, Dolores Eliche‐Quesada, Jun Hao Wang-Wang, Cristina Pitart, Francesc Marco, Núria Prim, Juan Pablo Horcajada, Eduardo Padilla, Ester del Barrio-Tofiño, Belen Viñado-Pérez, Nieves Larrosa, Fé Tubau, Sílvia Capilla, Antonio Casabella, Mar Olga Pérez-Moreno, Emma Padilla, Mónica Ballestero, Alba Rivera, Ferrán Navarro, Fréderic Gómez-Bertomeu, Sergio Pardo-Granell, Ester Picó-Plana, Dolores Guerrero, Carolina Sarvisé-Buil, Alba Bellés Bellés, Marta Fernández-Esgueva, María del Pilar Ortega-Lafont, Inmaculada García, Noelia Arenal-Andrés, Susana Hernando-Real, Rosario Ibáñez, Jesús Martı́nez, Federico Becerra, Carmen Aldea-Mansilla, Asmaa Alaoui-Sosse, José Carlos González, Julia Guzmán-Puche, Miguel Ángel Blázquez-Andrada, Nora Mariela Martínez-Ramírez, Alicia Beteta, Bárbara Gomila-Sard, Salvador Giner Almaraz, Eugenio Garduño, Pedro Miguel Juiz-González, Jorge Arca-Suárez, J. Corpas Alba, Pilar Alonso, Ana Isabel Rodríguez, María Isabel Paz-Vidal, Marta García‐Campello, Pablo Camacho, María de los Ángeles Pallarés, María Luisa Pérez del Molino, Amparo Coira, Gema Barbeito, Anniris Rincón ほか 30 名 - The Lancet Regional Health - Europe 2023 被引用: 82

  9. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Oliver, Olivier Barraud, Terramika Bellamy, Marc J. M. Bonten, Herman Goossens, Colin Reisner, Mark T. Esser, Hasan S. Jafri, The COMBACTE-MAGNET EVADE Study Group, Michael Joannidis, Walter Klimscha, Elisabeth De Waele, Jacques Devriendt, Vincent Huberlant, Pieter Depuydt, Sam Van Boxstael, Mladen Perić, Jasminka Kopić, Michal Hanauer, Tomas Hruby, Vladimír Šrámek, Petr Svoboda, Tomáš Vymazal, Martin Nováček, Djillali Annane, Jean‐Paul Mira, Bertrand Souweine, Pierre‐François Dequin, Ferhat Meziani, François Stéphan, Saadalla Nseir, Sébastien Gibot, Carole Schwebel, Gaëtan Plantefève, Jean‐Luc Diehl, Christian Richard, Christian Lamer, Kada Klouche, Samir Jaber, Epaminondas Zakynthinos, Georgios Filntisis, Spyros Zakynthinos, Antonia Koutsoukou, Georgios Saroglou, Charikleia Nikolaou, Glykeria Vlachogianni, Ioannis Pnevmatikos, Konstantinos Mandragos, Ildikó Krémer, Zsolt Dezso Rozgonyi, Zsuzsa Marjanek, Ignacio Martín‐Loeches, Pierre Singer, Vernon van Heerden, Yehuda Carmeli, Pedro Póvoa, Antonio Alvarez Seoane, Pedro Henrique de Moura, Filipe Gonzalez, Paula Ramírez, Antonio Torres Martí, Ricard Ferrer, Lorena Oteiza, D. Escudero, Enrique Piacentini, Paula Vera, Luis Tamayo, Miguel Angel Gonzalez Gallego, B. Suberviola Cañas, Iglesias Figueira ほか 18 名 - Critical Care 2022 被引用: 93

  10. The Versatile Mutational Resistome of Pseudomonas aeruginosa

    著者: , , , - Frontiers in Microbiology 2018 被引用: 258

  11. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms

    著者: , , , , - Biofilm 2023 被引用: 103

  12. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dóra Szabó, Arjana Tambić-Andrašević, Rossitza Vatcheva-Dobrevska, Astra Vitkauskienė, Katy Jeannot - Clinical Microbiology and Infection 2023 被引用: 94

  13. Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

    著者: , , , , , , , , , , , - Journal of Antimicrobial Chemotherapy 2022 被引用: 53

  14. High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection

    著者: , , , , - Science 2000 被引用: 1,479

  15. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2017 被引用: 171

  16. Pseudomonas aeruginosa: a clinical and genomics update

    著者: , , , , , , - FEMS Microbiology Reviews 2021 被引用: 89

  17. In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa

    著者: , , , , - Journal of Antimicrobial Chemotherapy 2023 被引用: 47

  18. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone

    著者: , , , , , , , , , , - Scientific Reports 2017 被引用: 173

  19. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent “β-Lactam Enhancer” Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones

    著者: , , , , , , , - Antimicrobial Agents and Chemotherapy 2017 被引用: 131

  20. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús Rodríguez‐Baño, M D del Toro, Juan Gálvez-Acebal, Marco Falcone, Alessandro Russo, Helen Giamarellou, Enrico Maria Trecarichi, Angela Raffaella Losito, Elisa García‐Vázquez, Alicia Hernández, J Gómez, Germán Bou, Εlias Iosifidis, Núria Prim, Ferrán Navarro, Beatriz Mirelis, Anna Skiada, Julia Origüen, R San Juan, Mario Fernández‐Ruiz, Nieves Larrosa, Mireia Puig‐Asensio, José Miguel Cisneros, José Molina, V. González, V. Rucci, E. Ruiz de Gopegui, C. Marinescu, Luis Martı́nez-Martı́nez, M.C. Fariñas, M.E. Cano, Mónica Gozalo, Marta Mora-Rillo, Carolina Navarro-San Francisco, Carmen Peña, Sílvia Gómez-Zorrilla, Fé Tubau, Athanasios Tsakris, Olympia Zarkotou, Anastasia Antoniadou, Garyphallia Poulakou, Johann Pitout, Divya Virmani, Julián Torre-Cisneros, Julia Guzmán-Puche, Özant Helvacı, Ahmet Şahin, Vicente Pintado, Pablo Ramos-Ruiz, Michele Bartoletti, Maddalena Giannella, E. Tacconelli, F Riemenschneider, Esther Calbo, Cristina Badía, Mariona Xercavins, Oriol Gasch, D. Fontanals, E. Jové - The Lancet Infectious Diseases 2017 被引用: 521

  21. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens

    著者: , , , , , , , , , , , , , , , , , , - Scientific Reports 2020 被引用: 111

  22. Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 68

  23. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Microbiology 2022 被引用: 65

  24. β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

    著者: , , , , , , - PLoS Pathogens 2009 被引用: 288